ApprovalTrail

Approval · Notice of Compliance 15875 · 2014

ASA EC: Notice of Compliance 15875

Issued July 24, 2014

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
15875
Date
July 24, 2014
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Nonprescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
Licensing agreement between two companies
Therapeutic class
Platelet aggregation inhibitor
Canadian reference product
COATED ASPIRIN DAILY LOW DOSE 81MG (Bayer Inc.)

Products in this notice

BrandDINStatus today
ASA EC02426811Dormant

Medicinal ingredients